Detalles de la búsqueda
1.
Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study.
Reprod Biol Endocrinol
; 22(1): 7, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166856
2.
Effect of GnRH agonist trigger with or without low-dose hCG on reproductive outcomes for PCOS women with freeze-all strategy: a propensity score matching study.
Arch Gynecol Obstet
; 309(2): 679-688, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032411
3.
Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence.
Reprod Biol Endocrinol
; 21(1): 67, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480081
4.
Why ovarian stimulation should be aimed to maximize oocyte yield.
Reprod Biomed Online
; 46(4): 655-658, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36746705
5.
Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle.
Cochrane Database Syst Rev
; 11: CD013827, 2023 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032057
6.
Introduce an optimal method of ovarian stimulation in the polycystic ovarian syndrome affected: a randomized controlled trial.
BMC Womens Health
; 23(1): 323, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340371
7.
Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach.
Gynecol Endocrinol
; 39(1): 2205952, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156263
8.
The ovarian hyperstimulation that truly matters: Admissions, severity and prevention strategies.
Aust N Z J Obstet Gynaecol
; 63(4): 583-587, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062907
9.
Beyond the Umbrella: A Systematic Review of the Interventions for the Prevention of and Reduction in the Incidence and Severity of Ovarian Hyperstimulation Syndrome in Patients Who Undergo In Vitro Fertilization Treatments.
Int J Mol Sci
; 24(18)2023 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762488
10.
Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage.
J Cell Mol Med
; 26(16): 4613-4623, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35866203
11.
Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future?
Hum Reprod
; 37(7): 1379-1387, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640162
12.
Con: freeze-all for all? One size does not fit all.
Hum Reprod
; 37(7): 1388-1393, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640167
13.
Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
Hum Reprod
; 37(8): 1795-1805, 2022 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595223
14.
Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection.
Reprod Biol Endocrinol
; 20(1): 147, 2022 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195924
15.
Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis.
Reprod Biol Endocrinol
; 20(1): 114, 2022 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941630
16.
Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
Gynecol Endocrinol
; 38(12): 1093-1096, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36579847
17.
Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model.
Gynecol Endocrinol
; 38(4): 318-323, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285758
18.
Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model.
Gynecol Endocrinol
; 38(2): 170-175, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964405
19.
Ovarian Hyperstimulation Syndrome after GnRH Agonist Triggering and Freeze-All Protocol? Never Not, Hardly Ever: A Systematic Review of Case Reports.
Gynecol Obstet Invest
; 87(5): 259-265, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36070703
20.
Algorithm-based individualization methodology of the starting gonadotropin dose in IVF/ICSI and the freeze-all strategy prevent OHSS equally in normal responders: a systematic review and network meta-analysis of the evidence.
J Assist Reprod Genet
; 39(7): 1583-1601, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551563